Publication

Study protocol: the improving care of acute lung injury patients (ICAP) study

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    Dale M Needham, Johns Hopkins UniversityCheryl R Dennison, Johns Hopkins UniversityDavid W Dowdy, Johns Hopkins UniversityPedro A Mendez-Tellez, Johns Hopkins UniversityNancy Ciesla, Johns Hopkins UniversitySanjay V Desai, Johns Hopkins UniversityJonathan Sevransky, Emory UniversityCarl Shanholtz, University of MarylandDaniel Scharfstein, Johns Hopkins UniversityMargaret S Herridge, University of TorontoPeter J Pronovost, Johns Hopkins University
Language
  • English
Date
  • 2006-01-01
Publisher
  • BioMed Central
Publication Version
Copyright Statement
  • © 2005 Needham et al.; licensee BioMed Central Ltd.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1364-8535
Volume
  • 10
Issue
  • 1
Start Page
  • R9
End Page
  • R9
Grant/Funding Information
  • DMN is supported by a Clinician-Scientist Award from the Canadian Institutes of Health Research, and a Detweiler Fellowship from the Royal College of Physicians and Surgeons of Canada.
  • This research is supported by National Institutes of Health (Acute Lung Injury SCCOR grant P050 HL 73994-01).
  • CRD is supported by a Mentored Patient-Oriented Research Career Development Award from the National Institutes of Health (K23 NR009193).
  • DWD is supported by a Medical Scientist Training Program Grant from the National Institutes of Health (award 5 T32 GMO7309).
Abstract
  • Introduction: The short-term mortality benefit of lower tidal volume ventilation (LTVV) for patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) has been demonstrated in a large, multi-center randomized trial. However, the impact of LTVV and other critical care therapies on the longer-term outcomes of ALI/ARDS survivors remains uncertain. The Improving Care of ALI Patients (ICAP) study is a multi-site, prospective cohort study that aims to evaluate the longer-term outcomes of ALI/ARDS survivors with a particular focus on the effect of LTVV and other critical care therapies. Methods: Consecutive mechanically ventilated ALI/ARDS patients from 11 intensive care units (ICUs) at four hospitals in the city of Baltimore, MD, USA, will be enrolled in a prospective cohort study. Exposures (patient-based, clinical management, and ICU organizational) will be comprehensively collected both at baseline and throughout patients' ICU stay. Outcomes, including mortality, organ impairment, functional status, and quality of life, will be assessed with the use of standardized surveys and testing at 3, 6, 12, and 24 months after ALI/ ARDS diagnosis. A multi-faceted retention strategy will be used to minimize participant loss to follow-up. Results: On the basis of the historical incidence of ALI/ARDS at the study sites, we expect to enroll 520 patients over two years. This projected sample size is more than double that of any published study of long-term outcomes in ALI/ARDS survivors, providing 86% power to detect a relative mortality hazard of 0.70 in patients receiving higher versus lower exposure to LTVV. The projected sample size also provides sufficient power to evaluate the association between a variety of other exposure and outcome variables, including quality of life. Conclusion: The ICAP study is a novel, prospective cohort study that will build on previous critical care research to improve our understanding of the longer-term impact of ALI/ARDS, LTVV and other aspects of critical care management. Given the paucity of information about the impact of interventions on long-term outcomes for survivors of critical illness, this study can provide important information to inform clinical practice.
Author Notes
Keywords
Research Categories
  • Health Sciences, Nursing
  • Health Sciences, General
  • Health Sciences, Health Care Management

Tools

Relations

In Collection:

Items